Veery Capital’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $66.1K | Hold |
14,163
| – | – | 0.02% | 94 |
|
|
2025
Q1 | $77.8K | Hold |
14,163
| – | – | 0.03% | 92 |
|
|
2024
Q4 | $48K | Hold |
14,163
| – | – | 0.02% | 91 |
|
|
2024
Q3 | $40.4K | Hold |
14,163
| – | – | 0.02% | 94 |
|
|
2024
Q2 | $31.9K | Hold |
14,163
| – | – | 0.01% | 96 |
|
|
2024
Q1 | $31.3K | Buy |
14,163
+1,619
| +13% | +$3.58K | 0.01% | 96 |
|
|
2023
Q4 | $29.5K | Hold |
12,544
| – | – | 0.01% | 90 |
|
|
2023
Q3 | $23.3K | Hold |
12,544
| – | – | 0.01% | 81 |
|
|
2023
Q2 | $32.9K | Hold |
12,544
| – | – | 0.02% | 85 |
|
|
2023
Q1 | $20.4K | Hold |
12,544
| – | – | 0.01% | 82 |
|
|
2022
Q4 | $16.7K | Hold |
12,544
| – | – | 0.01% | 71 |
|
|
2022
Q3 | $20K | Hold |
12,544
| – | – | 0.01% | 71 |
|
|
2022
Q2 | $19K | Buy |
+12,544
| New | +$19K | 0.01% | 73 |
|
|
2022
Q1 | – | Sell |
-12,544
| Closed | -$37K | – | 86 |
|
|
2021
Q4 | $37K | Buy |
+12,544
| New | +$37K | 0.02% | 81 |
|